Public health campaigners are ramping up pressure to share vaccine manufacturing knowledge and help other countries

How to beat the market! Readers respond to Andrew Leonard's "Warren Buffett's Revenge."

After bemoaning attacks from the "far left," Andrew Sullivan returns a sponsorship from the pharmaceutical industry.

With Michael Powell in charge at the FCC, more media megamergers are on the way.

New satellite tech could bring billions more online. But will Big Tech bring their extractive ethos into space?

Pro-business conservatives see U.S. public education budgets as pots of gold to be mined for private gain

The New York Times says the numbers don't add up. They do if you assume 3.8% unemployment and 5.3% rate of growth

A vaccine against tuberculosis has never been closer to reality. But development slowed due to corporate interests

"She has made a fan of me for life"

Author and psychologist Bruce Levine pummels psychiatry, psychotropic drugs and the role both may have played in the case of Andrea Yates.

GOP senators made shady stock trades while minimizing coronavirus — and yes, Liz Warren has a plan to stop that

"Price-gouging is central to the industry business model."

The only way to stem the flood of unwanted e-mail may be to harness a million eyeballs and an army of open-source hackers.

Roche says it will help poor countries make cheap drugs, no questions asked. Why?

A growing market allows investors to make money off of disease and natural disasters. And so far, their predictions have been dead-on.